AdaptHealth Corp. (NASDAQ:AHCO) Receives Consensus Rating of “Moderate Buy” from Brokerages

AdaptHealth Corp. (NASDAQ:AHCO) has been given an average recommendation of “Moderate Buy” by the nine ratings firms that are covering the company, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation and seven have issued a buy recommendation on the company. The average 12-month price target among analysts that have covered the stock in the last year is $14.1429.

Several research firms recently weighed in on AHCO. Robert W. Baird reduced their price objective on shares of AdaptHealth from $18.00 to $15.00 and set an “outperform” rating on the stock in a research note on Monday, July 6th. Canaccord Genuity Group upped their target price on shares of AdaptHealth from $14.00 to $16.00 and gave the company a “buy” rating in a research note on Wednesday, May 6th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of AdaptHealth in a research note on Friday, May 22nd. Jefferies Financial Group upgraded AdaptHealth from a “hold” rating to a “buy” rating and lifted their target price for the stock from $11.00 to $13.00 in a report on Tuesday. Finally, Royal Bank Of Canada boosted their target price on AdaptHealth from $13.00 to $15.00 and gave the company an “outperform” rating in a research note on Monday, May 11th.

Insider Buying and Selling at AdaptHealth

In other news, insider Russell E. Schuster III sold 11,275 shares of AdaptHealth stock in a transaction dated Monday, June 1st. The stock was sold at an average price of $10.06, for a total transaction of $113,426.50. Following the transaction, the insider owned 136,538 shares in the company, valued at $1,373,572.28. The trade was a 7.63% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 1.95% of the stock is owned by company insiders.

Institutional Trading of AdaptHealth

A number of large investors have recently bought and sold shares of the business. Rockefeller Capital Management L.P. raised its holdings in AdaptHealth by 433.0% during the 4th quarter. Rockefeller Capital Management L.P. now owns 2,585 shares of the company’s stock worth $26,000 after buying an additional 2,100 shares during the period. PNC Financial Services Group Inc. boosted its holdings in shares of AdaptHealth by 22.3% in the fourth quarter. PNC Financial Services Group Inc. now owns 7,003 shares of the company’s stock valued at $70,000 after buying an additional 1,279 shares during the period. Assetmark Inc. boosted its holdings in shares of AdaptHealth by 54.8% in the first quarter. Assetmark Inc. now owns 6,952 shares of the company’s stock valued at $83,000 after buying an additional 2,460 shares during the period. Tower Research Capital LLC TRC increased its position in shares of AdaptHealth by 318.0% during the second quarter. Tower Research Capital LLC TRC now owns 9,592 shares of the company’s stock worth $90,000 after acquiring an additional 7,297 shares in the last quarter. Finally, Tidal Investments LLC bought a new stake in shares of AdaptHealth during the second quarter worth $96,000. 82.67% of the stock is owned by institutional investors.

AdaptHealth Price Performance

AdaptHealth stock opened at $10.76 on Friday. The company has a current ratio of 0.92, a quick ratio of 0.71 and a debt-to-equity ratio of 1.21. The firm has a market capitalization of $1.46 billion, a P/E ratio of -17.35, a PEG ratio of 0.53 and a beta of 1.45. The business has a 50-day moving average of $10.24 and a 200-day moving average of $10.65. AdaptHealth has a 1 year low of $8.51 and a 1 year high of $13.43.

AdaptHealth Company Profile

AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.